查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1694908

2025年全球呼吸照护设备市场报告

Respiratory Inhaler Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年呼吸吸入装置的市场规模将强劲成长。到 2029 年，这一数字将成长至 595.5 亿美元，复合年增长率为 7.7%。预测期内的成长归因于对空气品质的担忧、数位健康的整合、对吸入器安全的监管重点以及个人化治疗。预测期内的主要趋势包括吸入器设备的小型化、永续性和环保吸入器、居家照护和技术进步。

呼吸系统疾病的盛行率不断上升，推动了呼吸吸入设备市场的成长。呼吸系统疾病包括影响肺部和呼吸系统的多种疾病，常常导致呼吸困难和肺功能下降。这些疾病包括气喘、慢性阻塞性肺病（COPD）、呼吸道融合细胞病毒感染疾病、以及多种其他呼吸系统疾病。使用呼吸吸入装置对于将药物直接输送到肺部至关重要，可以为患有呼吸系统疾病的人提供快速且准确的缓解。例如，美国着名公共卫生组织疾病管制与预防中心的最新数据显示，美国报告的结核病病例增加，从2021年的7,874例增加到2022年的8,300例。数据凸显了呼吸系统疾病盛行率不断上升产生的巨大驱动力，推动了呼吸吸入设备市场的扩张。

预计未来几年吸烟率的上升将推动呼吸吸入设备市场的成长。吸烟，即吸入和呼出燃烧的烟草和其他物质产生的蒸气，会损害肺部的气道和微小气囊（肺泡），并导致气喘、慢性阻塞性肺病和支气管炎等呼吸系统疾病。呼吸吸入装置对于缓解症状和防止进一步的呼吸困难对于控制这些状况至关重要。例如，2024年9月，美国政府机构疾病管制与预防中心（CDC）报告称，烟草使用仍然是美国可预防疾病和死亡的主要原因。 2022年，约有4,920万成年人（占19.8%），即近五分之一的人报告使用烟草製品。因此，吸烟率的上升正在推动呼吸吸入设备市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球呼吸吸入设备市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球呼吸照护设备市场：成长率分析
  • 全球呼吸照护设备市场表现：规模与成长，2019-2024
  • 全球呼吸照护设备市场预测：2024-2029 年、2034 年规模与成长
  • 呼吸护理设备的全球总目标市场（TAM）

第六章市场区隔

  • 全球呼吸吸入设备市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器
  • 定量喷雾吸入器
  • 喷雾器
  • 全球呼吸吸入设备市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 手动吸入器
  • 数位操作吸入器
  • 全球呼吸吸入设备市场（按适应症、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 气喘
  • 慢性阻塞性肺病
  • 肺动脉高血压
  • 其他的
  • 全球呼吸吸入设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 呼吸护理中心
  • 其他的
  • 全球呼吸吸入设备市场：干粉吸入器按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 单剂量吸入器
  • 多剂量吸入器
  • 全球呼吸吸入设备市场：定量喷雾吸入器按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 含氯氟烃的MDI
  • HFA基MDI
  • 全球呼吸吸入设备市场：雾化器细分市场（按类型、性能及预测），2019-2024 年、2024-2029 年、2034 年
  • 喷射雾化器
  • 超音波雾化器
  • 网状雾化器

第七章 区域和国家分析

  • 全球呼吸吸入设备市场各地区、绩效及预测（2019-2024、2024-2029、2034）
  • 全球呼吸吸入设备市场（依国家/地区、绩效及预测）2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 呼吸吸入器市场：竞争格局
  • 呼吸护理设备市场：公司简介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • 3M
  • Boehringer Ingelheim International GmbH
  • Koninklijke Philips NV
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • Perrigo Company plc
  • AptarGroup Inc.
  • Recipharm AB
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Zydus Lifesciences Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年呼吸护理设备市场：提供新机会的国家
  • 2029年呼吸吸入设备市场：细分市场带来新机会
  • 2029年呼吸照护设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r28885

Respiratory inhaler devices are compact, handheld tools designed to administer medication directly to the lungs. They are specifically engineered to deliver medications to the respiratory system, with a focus on the lungs, which helps minimize systemic drug effects and provides rapid relief during respiratory attacks or exacerbations.

The primary categories of respiratory inhaler device products include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers (DPIs) are medical devices that dispense powdered medications directly to the lungs for the treatment of respiratory conditions. These inhaler devices encompass both manually operated and digitally operated options. They are commonly used in the management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other respiratory issues. Respiratory inhaler devices find application in various healthcare settings, including hospitals, clinics, respiratory care centers, and other medical facilities. They serve as important tools for the delivery of respiratory medications and the management of respiratory conditions.

The respiratory inhaler devices market research report is one of a series of new reports from The Business Research Company that provides respiratory inhaler devices market statistics, including respiratory inhaler devices industry global market size, regional shares, competitors with a respiratory inhaler devices market share, detailed respiratory inhaler devices market segments, market trends and opportunities and any further data you may need to thrive in the respiratory inhaler devices industry. This respiratory inhaler devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $41.35 billion in 2024 to $44.33 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population.

The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $59.55 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to air quality concerns, digital health integration, regulatory emphasis on inhaler safety, personalized treatment. Major trends in the forecast period include inhaler device miniaturization, sustainability and eco-friendly inhalers, home-based care, technological advancements.

The prevalence of respiratory diseases is on the rise, and this phenomenon is poised to steer the growth of the respiratory inhaler devices market. Respiratory diseases encompass a spectrum of disorders that affect the lungs and the respiratory system, often resulting in breathing difficulties and compromised lung function. These conditions include ailments like asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection, and various other respiratory disorders. The utilization of respiratory inhaler devices is essential in delivering medications directly to the lungs, providing swift and precise relief for individuals battling respiratory illnesses. As an example, recent data from the Centers for Disease Control and Prevention, a prominent US-based public health organization, revealed an increase in tuberculosis (TB) cases reported in the United States, reaching 8,300 cases in 2022, up from 7,874 cases in 2021. This data underscores the significant impetus resulting from the growing prevalence of respiratory diseases, which propels the expansion of the respiratory inhaler devices market.

The rising smoking rates are expected to drive the growth of the respiratory inhaler devices market in the coming years. Smoking, which involves inhaling and exhaling the vapors of burning tobacco or other substances, can damage the airways and small air sacs (alveoli) in the lungs, leading to respiratory diseases such as asthma, COPD, and bronchitis. Respiratory inhaler devices are crucial for managing these conditions by alleviating symptoms and preventing further breathing difficulties. For instance, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that tobacco use remains the leading cause of preventable disease and death in the United States. In 2022, about 49.2 million adults, or 19.8%, nearly 1 in 5, reported using tobacco products. As a result, the increasing smoking rates are driving the growth of the respiratory inhaler devices market.

Prominent companies within the respiratory inhaler devices market are increasingly adopting advanced technologies, such as metered dosage inhalers (MDIs), to fortify their market standing. MDIs represent portable aerosol devices designed to deliver precise medication doses to the lungs in the form of an inhaled mist or spray. For instance, a noteworthy development occurred in February 2022, when AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital respiratory health solution effectively transforms conventional metered dosage inhalers (pMDIs) into intelligent and connected medical devices. HeroTracker Sense aims to monitor the utilization of MDIs by patients, promoting better adherence to prescribed therapies and ultimately enhancing the lives of individuals worldwide grappling with chronic respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory complications triggered by COVID-19. HeroTracker Sense further offers invaluable analytics and insights related to patient training, onboarding, and performance, serving healthcare providers (HCPs) through the Aptar Pharma Cohero Health BreatheSmart Connect portal.

In August 2022, AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, secured the global rights to the Orbital inhaler through an acquisition from Pharmaxis Ltd. This strategic acquisition of the Orbital inhaler rights aligns with Aptar Pharma's mission to expand its respiratory device portfolio and provide innovative solutions catering to patients grappling with respiratory conditions. Pharmaxis Ltd., an Australian-based pharmaceutical company with a clinical-stage focus, developed the groundbreaking Orbital dry powder inhaler. This strategic acquisition demonstrates a commitment to advancing respiratory care.

Major companies operating in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.

North America was the largest region in the respiratory inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory inhaler devices market consists of revenues earned by entities by providing services such as the management of chronic lung diseases and minimizing systemic effects of the drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory inhaler devices market also includes sales of compressed air nebulizers, ultrasonic nebulizers and mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Inhaler Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory inhaler devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory inhaler devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Technology: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease; Pulmonary Arterial Hypertension; Other Indications
  • 4) By End User: Hospitals And Clinics; Respiratory Care Centers; Other End Users
  • Subsegments:
  • 1) By Dry Powder Inhalers: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Metered Dose Inhalers: CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; AstraZeneca plc; Gerresheimer AG; GlaxoSmithKline plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Inhaler Devices Market Characteristics

3. Respiratory Inhaler Devices Market Trends And Strategies

4. Respiratory Inhaler Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Respiratory Inhaler Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Inhaler Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Inhaler Devices Market Growth Rate Analysis
  • 5.4. Global Respiratory Inhaler Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Inhaler Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Inhaler Devices Total Addressable Market (TAM)

6. Respiratory Inhaler Devices Market Segmentation

  • 6.1. Global Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Other Indications
  • 6.4. Global Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Respiratory Care Centers
  • Other End Users
  • 6.5. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Inhalers
  • Multi-Dose Inhalers
  • 6.6. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CFC-Based MDIs
  • HFA-Based MDIs
  • 6.7. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Respiratory Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Respiratory Inhaler Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Inhaler Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Inhaler Devices Market

  • 8.1. Asia-Pacific Respiratory Inhaler Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Inhaler Devices Market

  • 9.1. China Respiratory Inhaler Devices Market Overview
  • 9.2. China Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Inhaler Devices Market

  • 10.1. India Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Inhaler Devices Market

  • 11.1. Japan Respiratory Inhaler Devices Market Overview
  • 11.2. Japan Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Inhaler Devices Market

  • 12.1. Australia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Inhaler Devices Market

  • 13.1. Indonesia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Inhaler Devices Market

  • 14.1. South Korea Respiratory Inhaler Devices Market Overview
  • 14.2. South Korea Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Inhaler Devices Market

  • 15.1. Western Europe Respiratory Inhaler Devices Market Overview
  • 15.2. Western Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Inhaler Devices Market

  • 16.1. UK Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Inhaler Devices Market

  • 17.1. Germany Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Inhaler Devices Market

  • 18.1. France Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Inhaler Devices Market

  • 19.1. Italy Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Inhaler Devices Market

  • 20.1. Spain Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Inhaler Devices Market

  • 21.1. Eastern Europe Respiratory Inhaler Devices Market Overview
  • 21.2. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Inhaler Devices Market

  • 22.1. Russia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Inhaler Devices Market

  • 23.1. North America Respiratory Inhaler Devices Market Overview
  • 23.2. North America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Inhaler Devices Market

  • 24.1. USA Respiratory Inhaler Devices Market Overview
  • 24.2. USA Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Inhaler Devices Market

  • 25.1. Canada Respiratory Inhaler Devices Market Overview
  • 25.2. Canada Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Inhaler Devices Market

  • 26.1. South America Respiratory Inhaler Devices Market Overview
  • 26.2. South America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Inhaler Devices Market

  • 27.1. Brazil Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Inhaler Devices Market

  • 28.1. Middle East Respiratory Inhaler Devices Market Overview
  • 28.2. Middle East Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Inhaler Devices Market

  • 29.1. Africa Respiratory Inhaler Devices Market Overview
  • 29.2. Africa Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Inhaler Devices Market Competitive Landscape
  • 30.2. Respiratory Inhaler Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. 3M
  • 31.2. Boehringer Ingelheim International GmbH
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Viatris Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Catalent Inc.
  • 31.7. Perrigo Company plc
  • 31.8. AptarGroup Inc.
  • 31.9. Recipharm AB
  • 31.10. Chiesi Farmaceutici S.p.A.
  • 31.11. Cipla Limited
  • 31.12. Hikma Pharmaceuticals plc
  • 31.13. Zydus Lifesciences Limited
  • 31.14. Lupin Limited
  • 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Respiratory Inhaler Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Inhaler Devices Market

34. Recent Developments In The Respiratory Inhaler Devices Market

35. Respiratory Inhaler Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Inhaler Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Inhaler Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Inhaler Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer